SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

04 Aug 2022 Evaluate
The sales slipped to Rs. 4898.70 millions for the June 2022 quarter as against Rs. 5248.97 millions during the year-ago period.A humble growth in net profit of 7.75% reported in the quarter ended June 2022 to Rs. 1087.33  millions from Rs. 1009.13 millions.The Operating Profit of the company witnessed a decrease to 1562.61 millions from 1644.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4898.70 5248.97 -6.67 4898.70 5248.97 -6.67 21232.14 18851.65 12.63
Other Income 94.93 39.86 138.16 94.93 39.86 138.16 147.04 8.11 1713.07
PBIDT 1562.61 1644.34 -4.97 1562.61 1644.34 -4.97 6307.64 5918.85 6.57
Interest 1.35 205.50 -99.34 1.35 205.50 -99.34 279.62 875.47 -68.06
PBDT 1561.26 1438.84 8.51 1561.26 1438.84 8.51 6028.02 5043.38 19.52
Depreciation 98.79 89.19 10.76 98.79 89.19 10.76 378.77 333.94 13.42
PBT 1462.47 1349.65 8.36 1462.47 1349.65 8.36 5649.25 4709.44 19.96
TAX 375.14 340.52 10.17 375.14 340.52 10.17 1462.01 1193.63 22.48
Deferred Tax 12.85 18.09 -28.97 12.85 18.09 -28.97 85.74 66.17 29.58
PAT 1087.33 1009.13 7.75 1087.33 1009.13 7.75 4187.24 3515.81 19.10
Equity 245.05 215.61 13.65 245.05 215.61 13.65 245.05 19.60 1150.26
PBIDTM(%) 31.90 31.33 1.82 31.90 31.33 1.82 29.71 31.40 -5.38

Alivus Life Sciences Share Price

1066.65 -6.50 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×